Code | 9483D | ||||||||||
MA number | 59/0014/22-S | ||||||||||
Product Form: | cps dur 21x15 mg (blis.PVC/PCTFE/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PCTFE/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 13.02.2022 |
Validity: | 13.02.2027 |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 15.02.2022 |